Validation of the prognostic and predictive value of class III beta tubulin (TUBB3) for adjuvant chemotherapy (ACT) in completely resected non-small cell lung cancer (R-NSCLC): Results from four randomized trials
- Citation:
- J Thorac Oncol vol 4 (9 suppl 1) abstr A4.2
- Meeting Instance:
- IASLC (WCLC) 2009
- Year:
- 2009
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Secondary-not-in-original
- Analysis:
- Comprehensive
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 713
- Program:
- OGC
- Primary Committee:
- Respiratory
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Tony Reiman Pascal Seve Anne-Sophie Veillard Jean-Charles Soria Rafael Rosell Miquel Taron Stephen Graziano Robert Kratzke Lesley Seymour Frances Shepherd Jean-Pierre Pignon Raymond Lai
- Networks:
- Study
- CALGB-9633
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: